GGO Vergunningendatabase

Zoekcriteria

1. Rechtspersoon:
2. Uitgangs-organisme:
3. Procedure: Alle MA IG IM-MV IM-L
4. Dossiernummer:

1. Status: Alle Ter inzage Teruggetrokken Vergunning onherroepelijk In behandeling Besluit genomen Werkzaamheden gestart Kennisgeving niet ingestemd Besluit geweigerd Procedure afgerond Vergunning vernietigd Intrekkingsbesluit onherroepelijk Conceptvergunning gereed Vergunning verleend
2. Datum vergunning vanaf:
3. Datum vergunning t/m:

1. Trefwoorden:

Zoekresultaat

IM-MV 19-002_004	Universitair Medisch Centrum Utrecht	Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells	22-03-2021	Vergunning verleend
IM-MV 19-011_004	Erasmus MC	Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells	22-03-2021	Vergunning verleend
IM-MV 19-012_004	VU medisch centrum	Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumor cells	31-03-2021	Vergunning verleend
IM-MV 19-014_004	UMCG	Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells	22-03-2021	Vergunning verleend
IM-MV 20-015_000	AMC	A Clinical Study to Evaluate the Safety, Reactogenicity, Immunogenicity and Efficacy of an Ad26 and/or MVA-BN clinical vector for the prevention or treatment of infectious diseases	01-04-2021	Vergunning verleend